ETF Holdings Breakdown of RXRX

News associated with RXRX

Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 5.4% After Earnings Miss

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report)’s stock price fell 5.4% on Tuesday following a weaker than expected earnings announcement. The stock traded as low as $4.45 and last traded at $4.51. 7,052,787 shares were traded during trading, a decline of 44% from the average session volume of 12,553,666 shares. The stock had previously […] - 2025-05-08 05:42:51

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives $8.20 Consensus Price Target from Analysts

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) have received a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price target […] - 2025-05-08 05:04:58

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 9.6% on Disappointing Earnings

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) shares dropped 9.6% on Monday following a dissappointing earnings announcement. The company traded as low as $5.23 and last traded at $5.16. Approximately 9,031,494 shares were traded during trading, a decline of 28% from the average daily volume of 12,478,559 shares. The stock had previously closed at […] - 2025-05-07 05:54:42

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down on Disappointing Earnings

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) gapped down prior to trading on Monday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $5.70, but opened at $5.49. Recursion Pharmaceuticals shares last traded at $5.33, with a volume of 5,427,114 shares. The company reported ($0.50) earnings per share […] - 2025-05-06 05:10:57

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Bought by Mariner LLC

Mariner LLC boosted its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 32.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 111,063 shares of the company’s stock after buying an additional 27,499 shares during the quarter. […] - 2025-04-29 07:56:57

Barclays PLC Has $4.28 Million Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Barclays PLC trimmed its position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 9.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 633,125 shares of the company’s stock after selling 64,307 shares during the period. Barclays PLC’s holdings […] - 2025-04-28 07:59:05

JPMorgan Chase & Co. Sells 119,024 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

JPMorgan Chase & Co. trimmed its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 10.1% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,057,167 shares of the company’s stock after selling 119,024 shares during the period. JPMorgan Chase & Co.’s holdings in Recursion Pharmaceuticals were worth $7,146,000 at the end of […] - 2025-04-17 07:27:22

Geode Capital Management LLC Has $41.16 Million Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Geode Capital Management LLC boosted its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 12.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,087,149 shares of the company’s stock after acquiring an additional 655,238 shares during the quarter. Geode […] - 2025-04-16 08:14:51

Raymond James Financial Inc. Invests $609,000 in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Raymond James Financial Inc. acquired a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 90,107 shares of the company’s stock, valued at approximately $609,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in RXRX. Decker Retirement […] - 2025-04-07 07:51:05

Swiss National Bank Boosts Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Swiss National Bank grew its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 36.3% in the 4th quarter, Holdings Channel reports. The institutional investor owned 486,700 shares of the company’s stock after purchasing an additional 129,600 shares during the quarter. Swiss National Bank’s holdings in Recursion Pharmaceuticals were worth $3,290,000 as of its […] - 2025-03-27 08:12:59

RXRX Quantitative Stock Analysis - Benjamin Graham

Below is Validea's guru fundamental report for RECURSION PHARMACEUTICALS INC (RXRX). Of the 22 guru strategies we follow, RXRX rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that hav - 2025-03-18 18:58:04

Private Advisor Group LLC Purchases 16,008 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Private Advisor Group LLC increased its stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 103.8% in the fourth quarter, Holdings Channel reports. The firm owned 31,427 shares of the company’s stock after purchasing an additional 16,008 shares during the period. Private Advisor Group LLC’s holdings in Recursion Pharmaceuticals were worth $212,000 as of […] - 2025-03-07 08:41:03

IFP Advisors Inc Purchases 7,455 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

IFP Advisors Inc lifted its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 170.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,831 shares of the company’s stock after acquiring an additional 7,455 shares during the quarter. IFP […] - 2025-03-06 10:45:49

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 5.3% After Earnings Miss

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) was down 5.3% during mid-day trading on Monday following a weaker than expected earnings announcement. The stock traded as low as $7.07 and last traded at $7.11. Approximately 8,143,605 shares were traded during trading, a decline of 68% from the average daily volume of 25,618,289 shares. The […] - 2025-03-04 06:55:13

Atria Wealth Solutions Inc. Takes $75,000 Position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Atria Wealth Solutions Inc. purchased a new stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 11,123 shares of the company’s stock, valued at approximately $75,000. A number of other institutional investors also recently bought and sold shares of the stock. Allspring […] - 2025-03-03 08:25:03

Pre-Market Most Active for Feb 28, 2025 : NVDA, TSLL, IBIT, SMCI, RXRX, SQQQ, FUBO, NIO, BABA, QBTS, ACHR, IONQ

The NASDAQ 100 Pre-Market Indicator is up 27.28 to 20,578.23. The total Pre-Market volume is currently 108,919,621 shares traded.The following are the most active stocks for the pre-market session: NVIDIA Corporation (NVDA) is -3.14 at $117.01, with 14,573,938 shares traded. As - 2025-02-28 13:29:59

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock Position Raised by Global Retirement Partners LLC

Global Retirement Partners LLC boosted its holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 31.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,297 shares of the company’s stock after acquiring an additional 7,500 shares during the period. Global Retirement […] - 2025-02-26 09:54:55

Pre-Market Most Active for Feb 19, 2025 : NIVF, INTC, TSLL, SMCI, NVDA, RXRX, NIO, SAN, BBAI, STM, ACHR, IONQ

The NASDAQ 100 Pre-Market Indicator is down -42.83 to 22,121.78. The total Pre-Market volume is currently 209,799,309 shares traded.The following are the most active stocks for the pre-market session: NewGenIvf Group Limited (NIVF) is +1.19 at $3.38, with 1,474,660 shares traded - 2025-02-19 09:31:20

Why Recursion Pharmaceuticals Stock Is Soaring Today

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) had soared by 15.8% as of 12:06 p.m. ET on Friday. Did the clinical-stage biotech company report great news? Nope. Instead, the stock's gains appeared to be driven by moves made by Nvidia (NASDAQ: NVDA). - 2025-02-14 17:07:40

Pre-Market Most Active for Feb 14, 2025 : STAI, SOUN, TSLL, INTC, RXRX, BABA, WRD, BBAI, NIO, NEE, QBTS, HIMS

The NASDAQ 100 Pre-Market Indicator is down -4.94 to 22,025.77. The total Pre-Market volume is currently 140,687,651 shares traded.The following are the most active stocks for the pre-market session: ScanTech AI Systems Inc. (STAI) is +0.73 at $2.41, with 19,507,309 shares trade - 2025-02-14 13:28:55

Pre-Market Most Active for Feb 6, 2025 : BBAI, IVVD, RXRX, TSLL, NVDA, F, RBLX, AMPS, IP, PTON, TSLA, QBTS

The NASDAQ 100 Pre-Market Indicator is up 8.85 to 21,667.01. The total Pre-Market volume is currently 110,392,939 shares traded.The following are the most active stocks for the pre-market session: BigBear.ai, Inc. (BBAI) is +0.1598 at $7.27, with 20,586,247 shares traded., follo - 2025-02-06 13:28:56

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Sold by Chicago Partners Investment Group LLC

Chicago Partners Investment Group LLC decreased its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 35.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 10,272 shares of the company’s stock after selling 5,702 shares during the period. Chicago Partners Investment Group LLC’s holdings in Recursion Pharmaceuticals were worth $75,000 […] - 2025-02-06 08:36:53

Clear Creek Financial Management LLC Buys 7,095 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Clear Creek Financial Management LLC lifted its stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 57.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 19,408 shares of the company’s stock after acquiring an additional 7,095 shares during the period. Clear Creek Financial Management […] - 2025-02-04 09:01:15

Exchange Traded Concepts LLC Buys 25,579 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Exchange Traded Concepts LLC increased its stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 101.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,761 shares of the company’s stock after purchasing an additional 25,579 shares during the period. Exchange Traded […] - 2025-01-31 08:36:57

RXRX institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	161,442	USD 708,730
2025-05-08	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	158,012	USD 693,673 4.6%
2025-05-08	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	222,951	USD 978,755 4.6%
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	189,276	USD 830,922
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	189,276	USD 830,922 4.6%
2025-05-08	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	4,437	USD 19,478 4.6%
Total =		925,394	USD 4,062,480

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer